Search
  1. Home
  2. Africa

MSF lauds WHO treatment objectives

    JOHANNESBURG

    The objectives of the World Health Organisation (WHO) to treat three million people living with HIV/AIDS by 2005, unveiled on World AIDS Day, were welcomed by the international medical NGO, Medecins Sans Frontieres (MSF).

    WHO also moved closer to meeting its target with the announcement that a quality-assured twice-a-day pill was available to treat HIV/AIDS.

    Dr Morten Rostrup, the president of MSF's international council, said in a statement: "Reducing the number of pills that patients have to take makes treatment much simpler and more affordable."

    Following the launch of the WHO objectives, MSF said getting treatment to the millions who needed it required treatment models that were much better adapted to resource-poor settings.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join